SecBot SecBot
SC 13G/A ·Filed Nov 5, 2026

GPCR

Structure Therapeutics Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed11d 10h ago SEC0000315066-26-002858
Passive stake amendment
Actionable Insight • Neutral

Fidelity's passive stake remains unchanged at 15.0%, indicating no material conviction shift. Monitor next 13F filing for any position changes and watch for any conversion to 13D if Fidelity's intent changes.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$19.08
T+0 close · Nov 5, 2026 · via day close
Latest settled
+3.98%
T+5 · $19.84
Vs SPY
+0.69%
α at T+5
Next horizon
T+20
in 17d
  1. T+0 · Nov 5 $19.08entry
  2. T+1 · 11d ago +6.66%α +6.34% · $20.35
  3. T+5 · 5d ago +3.98%α +0.69% · $19.84
  4. T+7 · todayOpen
  5. T+20 · in 17d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

FMR LLC (Fidelity) filed an amended Schedule 13G reporting beneficial ownership of 32,089,434 shares of Structure Therapeutics Inc. (GPCR) as of September 30, 2026, representing 15.0% of outstanding common stock. This is a routine passive stake update with no change in the reported percentage from the prior filing, indicating Fidelity maintained its position.

Key Financial Metrics

Stake
15%
Investor
FMR LLC
Investor Type
mutual fund

Key Facts

  • FMR LLC reported beneficial ownership of 32,089,434 shares of GPCR common stock as of September 30, 2026.
  • The stake represents 15.0% of outstanding shares.
  • This is an amendment to Schedule 13G, confirming passive investment intent.
  • The filing date is November 5, 2026, with a beneficial ownership date of September 30, 2026.

Financial Impact

No change in stake percentage; Fidelity continues to hold 15.0% of GPCR.

Risk Factors

  • No material risks identified from this routine passive stake update.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
91% bullish (23 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0000315066-26-002858
Document: 0000315066-26-002858-index-headers.html0000315066-26-002858
Document: 0000315066-26-002858-index.html0000315066-26-002858
Document: 0000315066-26-002858.txt0000315066-26-002858

Track record

10 reports on GPCR

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $19.16 Now $18.57 −3.08% settles Feb 12
  2. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry price pending
  3. Nov 9, 20267d ago Press Release Neutral 4/10 Entry $21.73 Now $18.57 −14.54% settles Feb 8
  4. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Viewing Entry $19.08 Now $18.57 −2.67% settles Feb 3
  5. Jun 11, 202622w ago Institutional Cluster Bearish 5/10 Entry $43.30 to $47.34 Now $18.57 +57.11% ▼ −9.33% −4.93% vs SPY
  6. May 7, 202627w ago 8-K Mixed 6/10 Entry $39.10 to $49.64 Now $18.57 −52.51% ▲ +26.96% +22.12% vs SPY
  7. Apr 27, 202629w ago Press Release Neutral 2/10 Entry $43.56 to $50.80 Now $18.57 −57.37% ▲ +16.62% +12.63% vs SPY
  8. Apr 15, 202630w ago 8-K Neutral 3/10 Entry $54.25 to $53.36 Now $18.57 −65.77% ▼ −1.64% −9.78% vs SPY
  9. Mar 16, 202635w ago Press Release Bullish 8/10 Entry $56.65 to $37.77 Now $18.57 −67.22% ▼ −33.33% −43.81% vs SPY
  10. Feb 28, 202637w ago Institutional Cluster Mixed 6/10 Entry $62.90 to $39.58 Now $18.57 −70.48% ▼ −37.07% −46.40% vs SPY
Showing 10 of 10

US Market Status

Market Closed · Opens Wed (9h 31m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026